Hidden Opportunities, A Strategic Compliance Series: A “Dope” Response to Pharmacy Transparency

A "Dope" Response to Pharmacy Transparency

You can now access a replay of this webinar here.

Join us on Thursday, March 17 from 12:00 to 12:30 CST for the third webinar in Humaculture, Inc.’s Hidden Opportunities, Strategic Compliance Series, to learn why the new pharmacy transparency law will not increase transparency; will increase costs, administration, and litigation risk; and how to effectively respond.

Presenters

Objective

Beyond basic compliance, this series addresses how to strategically leverage the No Surprises Act and Transparency in Coverage to create a competitive advantage for both the employer and employees. In this session we will include a focus on leveraging Acquisition Cost Based Pharmacy Pricing as well as Behavioral Design and Messaging as an example of a strategic action organizations can take to optimize this compliance opportunity.

Pharmacy Transparency Key Takeaways

During this session, participants will learn:

  • Transparency is a misnomer – New rules don’t provide transparency
  • Pharmacy is likely to continue to be rather “opaque”
  • The conundrum – mere compliance will likely increase costs, administration, and litigation risk
  • How to use Acquisition Cost Based Pharmacy Pricing as well as Behavioral Design and Messaging as examples of strategic actions to:
    • Avoid what can be avoided
    • Provide true transparency with pharmacy benefits
    • Empower consumers to make better, more clinically appropriate decisions
    • Communicate all negatives as the result of compliance
    • Inform/educate consumers (before they become patients)

Leave a Reply

Your email address will not be published.